Inherited variations in catecholamine metabolism are thought to underlie individual differences in neurophysiology and susceptibility to disease. These studies are aimed at understanding the genetic basis of variations in the structure and regulation of monoamine oxidases (MAO, E.C.1.4.3.4.), the enzymes primarily responsible for the degradation of amine neurotransmitters. Efforts will be directed first to cloning cDNAs for MAO using mRNA from several species - bovine, rodent and human, and several molecular biologic strategies including expression vector libraries, immunoaffinity purification of mRNA and synthetic oligonucleotides. Molecular genetic and biochemical methods will then be used to determine whether the A and B forms of MAO, which appear to have different structures and discrete functions in the nervous system, are encoded in separate genes and subject to distinct regulatory controls. Genes will be isolated from human genomic libraries and characterized with respect to sequence and intron/exon positions. Their chromosomal location will be determined using somatic cell hybrids and/or in situ hybridization to metaphase chromosomes. Linkage analyses will be carried out in human pedigrees to establish whether inherited variations in platelet MAO-B activity are determined by the structural gene for MAO-B using DNA polymorphisms and genomic blotting. Regulation of gene expression will be monitored by the sizes and amount of mRNA present under culture conditions where levels of MAO-A or MAO-B are changing. These include increased MAO-A activity in rat sympathetic neurons manifesting adrenergic versus cholinergic phenotype and in human skin fibroblasts exposed to glucocorticoids, as well as elevation of MAO-B activity in newborn mouse astrocytes as they proceed through their normal developmental sequence. Monoamine oxidase offers several intriguing phenomena for understanding neural functions - how multiple forms of the same enzyme have evolved and are used to effect different functions, how inherited variations in activity are determined, and how genes are developmentally and hormonally regulated.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS021921-09
Application #
3403637
Study Section
Neurology C Study Section (NEUC)
Project Start
1984-08-01
Project End
1992-06-30
Budget Start
1991-07-01
Budget End
1992-06-30
Support Year
9
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Schuback, D E; Mulligan, E L; Sims, K B et al. (1999) Screen for MAOA mutations in target human groups. Am J Med Genet 88:25-8
Tivol, E A; Shalish, C; Schuback, D E et al. (1996) Mutational analysis of the human MAOA gene. Am J Med Genet 67:92-7
Schuback, D E; Chen, Z Y; Craig, I W et al. (1995) Mutations in the Norrie disease gene. Hum Mutat 5:285-92
Hotamisligil, G S; Girmen, A S; Fink, J S et al. (1994) Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease. Mov Disord 9:305-10
Chen, Z Y; Battinelli, E M; Fielder, A et al. (1993) A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nat Genet 5:180-3
Brunner, H G; Nelen, M; Breakefield, X O et al. (1993) Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262:578-80
Sims, K B; Lebo, R V; Benson, G et al. (1992) The Norrie disease gene maps to a 150 kb region on chromosome Xp11.3. Hum Mol Genet 1:83-9
Chen, Z Y; Powell, J F; Hsu, Y P et al. (1992) Organization of the human monoamine oxidase genes and long-range physical mapping around them. Genomics 14:75-82
Konradi, C; Ozelius, L; Breakefield, X O (1992) Highly polymorphic (GT)n repeat sequence in intron II of the human MAOB gene. Genomics 12:176-7
Titlow, C C; Andersen, J K; Trofatter, J A et al. (1992) In vitro translation of proteins with terminal deletions by SP6 RNA polymerase-mediated transcription of PCR products. PCR Methods Appl 2:172-4

Showing the most recent 10 out of 27 publications